AKAP 250 Antibodies

Santa Cruz Biotechnology features a diverse variety of AKAP 250 monoclonal antibodies for research in understanding A-kinase anchoring protein 250. AKAP 250 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 250, also known as AKAP-Lbc, functions as a scaffolding protein that organizes signaling complexes within cells. AKAP 250 regulates protein kinase A (PKA) and protein kinase C (PKC) signaling pathways, which control cell growth, differentiation, and response to hormonal signals. Research has shown AKAP 250's significance in cardiovascular diseases and cancer development. AKAP 250 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. Investigating AKAP 250 helps reveal mechanisms behind cellular signaling networks and their impact on disease progression. Understanding AKAP 250's role in PKA and PKC pathways provides valuable insights into potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for AKAP 250 support researchers worldwide in advancing scientific knowledge of cellular signaling mechanisms and disease pathways.